维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="M. Zoli"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women显示文摘	N. Pedersen A. Bortoli D. Duricova R. D′Inca M. R. Panelli J. P. Gisbert G. Zoli A. López‐Sanromán F. Castiglione G. Riegler V. Annese P. Gionchetti A. Prada E. D. Pont A. Timmer C. Felley M. Shuhaibar E. V. Tsianos C. Dejaco F. J. Baert T. Jess M. Lebech	2013	Aliment Pharmacol Ther2013，，5：	2
	2	New abdominal collaterals at ultrasound: A clue of progression of portal hypertension显示文摘	A. Berzigotti C. Merkel D. Magalotti C. Tiani S. Gaiani D. Sacerdoti M. Zoli	2007	Digestive and Liver Disease2007，，1：	1
	3	Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes显示文摘	Antonio Muscari Giovanni M. Puddu Andrea Cenni Maria G. Silvestri Rosa Giuzio Marzia Rosati Nadia Santoro Giampaolo Bianchi Donatella Magalotti Marco Zoli	2008	Thrombosis Research2008，，4：	1
	4	Rise and fall of HCV ‐related hepatocellular carcinoma in Italy: a long‐term survey from the ITA . LI . CA centres显示文摘	Nora Cazzagon Franco Trevisani Gemma Maddalo Anna Giacomin Veronica Vanin Caterina Pozzan Paolo Del Poggio Gianludovico Rapaccini Anna M. Di Nolfo Luisa Benvegnù Marco Zoli Franco Borzio Edoardo G. Giannini Eugenio Caturelli Maria Chiaramonte Francesco G.	2013	Liver Int2013，，9：	1
	5	Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism显示文摘	F.W. Guglielmi C. Panella A. Buda G. Budillon L. Caregaro C. Clerici D. Conte A. Federico G. Gasbarrini A. Guglielmi C. Loguercio A. Losco D. Martines S. Mazzuoli M. Merli G. Mingrone A. Morelli G. Nardone G. Zoli A. Francavilla	2005	Digestive and Liver Disease2005，，：	1
	6	纳多洛尔对肝硬化患者的初级预防:对患者内脏血流动力学的多普勒模式效应比较显示文摘Background/Aims: We aimed to characterize by echo-color-Doppler the splanchnic hemodynamics of patients good and poor responders to primary prophylaxis with nadolol. Methods: Thirty cirrhotic patients (Child-score 7.0± 1.8) with medium/large esophageal varices without previous bleedings were consecutively enrolled. At inclusion and after 3 months of treatment with nadolol, they underwent a splanchnic echo-color-Doppler study and a measurement of hepatic venous pressure gradient (HVPG). Results: Nadolol (60± 36 mg/day; range 20-160) induced a significant reduction of HVPG (16.6± 6.1 vs. 19.4± 4.6 mmHg, P< 0.0001). 13 patients (43.3% ) were hemodynamic responders. Responders and Poor-res-ponders had similar baseline clinical characteristics. Poor-responders at baseline were characterized by lower impedance indexes in superior mesenteric artery (SMA) (PI 2.29± 0.45 vs. 2.74± 0.46; P=0.01; RI 0.83± 0.04 vs. 0.86± 0.03; P=0.02), hepatic artery (HA) (PI 1.41± 0.19 vs. 1.79± 0.48; P=0.03; RI 0.71± 0.05 vs. 0.80± 0.07; P=0.02), and splenic artery (SA) (PI 1.18± 0.27 vs. 1.73± 0.40; P=0.01; RI 0.66± 0.07 vs. 0.73± 0.09; P=0.02), and by higher mean flow velocity of HA (52.6± 21.6 vs. 26.5± 9.5 cm/s; P=0.02) and SMA (49.7± 14.5 vs. 33.9± 13.1 cm/s; P=0.06). Conclusions: Cirrhotic patients poor-responders to nadolol show a pronounced arterial splanchnic vasodilatation at a baseline echo-color-Doppler study. This can be considered a non-invasive clue for the a priori identification of this subgroup of patients.	Berzigotti A. Rinaldi M.F. Magalotti D. M. Zoli 赵菊辉	2006	世界核心医学期刊文摘(胃肠病学分册)2006，2，5：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费